Coverage
-
August 13, 2015
Eli Lilly & Co. on Thursday defeated claims that it concealed the withdrawal risks of its antidepressant Cymbalta when a California federal judge cut short a trial and issued a directed verdict for the drugmaker, less than a week after jurors in another California suit cleared the company.
6 other articles on this case.
View all »